An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Not Applicable
Active, not recruiting
- Conditions
- Neoplasms of the Prostate
- Interventions
- Device: AuroShell particle infusion
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04240639
- Locations
- ๐บ๐ธ
University of Michigan, Ann Arbor, Michigan, United States
๐บ๐ธHuntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
๐บ๐ธMayo Clinic Urology, Rochester, Minnesota, United States
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Not Applicable
Completed
- Conditions
- Neoplasms of the Prostate
- Interventions
- Device: AuroShell particle infusion
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT02680535
- Locations
- ๐บ๐ธ
University of Michigan, Ann Arbor, Michigan, United States
๐บ๐ธJohns Hopkins Hospital, Baltimore, Maryland, United States
๐บ๐ธThe University of Texas Medical Branch, Galveston, Texas, United States
Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
Not Applicable
Terminated
- Conditions
- Primary or Metastatic Lung Tumors
- First Posted Date
- 2012-09-06
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT01679470
- Locations
- ๐บ๐ธ
Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States
Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck
Not Applicable
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Device: AuroLase Therapy
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00848042
- Locations
- ๐บ๐ธ
Cancer Treatment Centers of American Western Regional Medical Center, Goodyear, Arizona, United States
๐บ๐ธBaylor College of Medicine, Houston, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath